Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
Enovis (NYSE: ENOV) has announced it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2024 financial results on Wednesday, February 26th, 2025 at 8:30 a.m. Eastern Time. The company will release its earnings press release earlier that morning.
A presentation related to the call will be accessible from the 'Investors' section of Enovis' website. Investors can participate by dialing (833) 685-0901 for U.S. callers and (412) 317-5715 for International callers. A replay of the call will be available on the company's website later that day.
Enovis (NYSE: ENOV) ha annunciato che ospiterà una conference call per investitori e una diretta web per discutere i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 mercoledì 26 febbraio 2025 alle 8:30 ora orientale. La società rilascerà il comunicato stampa sugli utili in quella mattina stessa.
Una presentazione relativa alla chiamata sarà accessibile dalla sezione 'Investitori' del sito web di Enovis. Gli investitori possono partecipare componendo il numero (833) 685-0901 per i chiamanti degli Stati Uniti e (412) 317-5715 per i chiamanti internazionali. Una registrazione della chiamata sarà disponibile sul sito web della società più tardi nella giornata.
Enovis (NYSE: ENOV) ha anunciado que llevará a cabo una conferencia telefónica para inversores y una transmisión en vivo para discutir sus resultados financieros del cuarto trimestre y del año completo 2024 el miércoles 26 de febrero de 2025 a las 8:30 a.m. hora del este. La compañía publicará su comunicado de ganancias antes esa mañana.
Una presentación relacionada con la llamada estará disponible en la sección 'Inversores' del sitio web de Enovis. Los inversores pueden participar marcando el (833) 685-0901 para llamadas dentro de EE. UU. y (412) 317-5715 para llamadas internacionales. Una repetición de la llamada estará disponible en el sitio web de la empresa más tarde ese día.
Enovis (NYSE: ENOV)는 2025년 2월 26일 수요일 오전 8시 30분 동부 표준시 기준으로 2024년 4분기 및 연간 재무 결과에 대한 투자자 컨퍼런스 콜과 생중계를 개최한다고 발표했습니다. 회사는 그날 아침 일찍 수익 보도자료를 발표할 예정입니다.
통화와 관련된 프레젠테이션은 Enovis 웹사이트의 '투자자' 섹션에서 확인할 수 있습니다. 투자자는 미국 전화 호출자는 (833) 685-0901, 국제 전화 호출자는 (412) 317-5715로 참여할 수 있습니다. 통화의 재생은 그날 나중에 회사 웹사이트에서 제공될 것입니다.
Enovis (NYSE: ENOV) a annoncé qu'elle tiendra une conférence téléphonique pour investisseurs et un webinaire en direct pour discuter de ses résultats financiers du quatrième trimestre et de l'année entière 2024 le mercredi 26 février 2025 à 8h30, heure de l'Est. L'entreprise publiera son communiqué de résultats plus tôt dans la matinée.
Une présentation en lien avec l'appel sera accessible dans la section 'Investisseurs' du site web d'Enovis. Les investisseurs peuvent participer en composant le (833) 685-0901 pour les appelants aux États-Unis et le (412) 317-5715 pour les appelants internationaux. Un enregistrement de l'appel sera disponible sur le site web de l'entreprise plus tard dans la journée.
Enovis (NYSE: ENOV) hat angekündigt, dass es am Mittwoch, den 26. Februar 2025, um 8:30 Uhr Eastern Time eine Telefonkonferenz für Investoren und einen Live-Stream abhalten wird, um über seine Finanzergebnisse des vierten Quartals und des gesamten Jahres 2024 zu berichten. Das Unternehmen wird zuvor an diesem Morgen eine Pressemitteilung zu den Ergebnissen veröffentlichen.
Eine Präsentation im Zusammenhang mit dem Anruf wird im Abschnitt 'Investoren' der Website von Enovis verfügbar sein. Investoren können teilnehmen, indem sie (833) 685-0901 für Anrufer aus den USA und (412) 317-5715 für internationale Anrufer wählen. Eine Wiederholung des Anrufs wird später am Tag auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2024 financial results on Wednesday, February 26th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call as well as a webcast can be accessed from the "Investors" section of Enovis' website at www.enovis.com.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
When will Enovis (ENOV) report Q4 and full year 2024 earnings?
How can investors access Enovis's (ENOV) Q4 2024 earnings call?
Will there be a replay available for Enovis's (ENOV) Q4 2024 earnings call?